| No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
| 1 |
rs10774925 |
chr12:117882412-117882413 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
| 2 |
rs565672994 |
chr12:117882460-117882461 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 3 |
rs534296759 |
chr12:117882477-117882478 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 4 |
rs34674165 |
chr12:117882481-117882482 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 5 |
rs77404221 |
chr12:117882533-117882534 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 6 |
rs3850605 |
chr12:117882534-117882535 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 7 |
rs77069077 |
chr12:117882535-117882536 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 8 |
rs188819542 |
chr12:117882639-117882640 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 9 |
rs3844051 |
chr12:117882701-117882702 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
| 10 |
rs551035347 |
chr12:117882703-117882704 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 11 |
rs77254556 |
chr12:117882716-117882717 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 12 |
rs370827041 |
chr12:117882717-117882718 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 13 |
rs374264931 |
chr12:117882801-117882802 |
Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 14 |
rs573203570 |
chr12:117882822-117882823 |
Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 15 |
rs368654831 |
chr12:117882839-117882840 |
Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 16 |
rs562090857 |
chr12:117882945-117882946 |
Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 17 |
rs574437628 |
chr12:117882956-117882957 |
Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 18 |
rs145615229 |
chr12:117882989-117882990 |
Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 19 |
rs115126054 |
chr12:117883059-117883060 |
Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 20 |
rs532129561 |
chr12:117883181-117883182 |
Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 21 |
rs138214327 |
chr12:117883221-117883222 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 22 |
rs142808299 |
chr12:117883234-117883235 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 23 |
rs146026467 |
chr12:117883315-117883316 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 24 |
rs547906557 |
chr12:117883316-117883317 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 25 |
rs568062426 |
chr12:117883361-117883362 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 26 |
rs537784888 |
chr12:117883397-117883398 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 27 |
rs7312290 |
chr12:117883413-117883414 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
| 28 |
rs12298014 |
chr12:117883420-117883421 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 29 |
rs149289808 |
chr12:117883428-117883429 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 30 |
rs144554781 |
chr12:117883457-117883458 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 31 |
rs553513347 |
chr12:117883467-117883468 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 32 |
rs573284038 |
chr12:117883479-117883480 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 33 |
rs535939826 |
chr12:117883484-117883485 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 34 |
rs570990281 |
chr12:117883519-117883520 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 35 |
rs193045362 |
chr12:117883534-117883535 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 36 |
rs575195549 |
chr12:117883563-117883564 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 37 |
rs60565143 |
chr12:117883584-117883585 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 38 |
rs370890548 |
chr12:117883587-117883588 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 39 |
rs80138955 |
chr12:117883590-117883591 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 40 |
rs76689691 |
chr12:117883591-117883592 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 41 |
rs35912647 |
chr12:117883608-117883609 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 42 |
rs76794209 |
chr12:117883634-117883635 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 43 |
rs184419861 |
chr12:117883647-117883648 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 44 |
rs576644484 |
chr12:117883650-117883651 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 45 |
rs545714791 |
chr12:117883651-117883652 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 46 |
rs559479611 |
chr12:117883678-117883679 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 47 |
rs556527994 |
chr12:117883683-117883684 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 48 |
rs541798275 |
chr12:117883692-117883693 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 49 |
rs561376051 |
chr12:117883706-117883707 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 50 |
rs528222799 |
chr12:117883719-117883720 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|